Enzybel Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Employees
  • 5


  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 2

Enzybel General Information


Developer of plant and animal-derived enzymes designed to produce and commercialize compounds derived from nature. The company's enzymes are extracts such as papain, bromelain, ficin, and actinidin which are derived from vegetables, plant proteases for food, domestic animals, nutraceuticals, and cosmetics, enabling pharmaceutical companies to improve their products organically.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Specialty Chemicals
Other Industries
Multi-line Chemicals
Corporate Office
  • 161/4 bat p
  • Drève Richelle
  • 1410 Waterloo
  • Belgium
+32 02 000 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Enzybel Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC Completed Generating Revenue
1. Accelerator/Incubator 09-Feb-2011 Completed Generating Revenue
To view Enzybel’s complete valuation and funding history, request access »

Enzybel Patents

Enzybel Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-881480-A Method for separating extract of hops into soft resins and hard resins Inactive 21-Sep-1971
ES-369578-A1 Method for separating extract of hops into soft resins and hard resins Inactive 17-Jul-1968 00000000
AU-5796069-A Method for separating extrct of hops into soft resins and hard resins Inactive 17-Jul-1968
GB-1241896-A Method for separating extract of hops into soft resins and hard resins Inactive 17-Jul-1968 00000000
DE-1933703-A1 Process for the separation of a hop extract into soft and hard resins Pending 17-Jul-1968 C12C3/08
To view Enzybel’s complete patent history, request access »

Enzybel Executive Team (4)

Name Title Board Seat Contact Info
Vinoth Kannan Chief Executive Officer
Patrick Deprez Chief Technical Officer
You’re viewing 2 of 4 executive team members. Get the full list »

Enzybel Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Enzybel Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Science Center Accelerator/Incubator Minority 000 0000 000000 0
Florinvest Corporate Venture Capital Minority 000 0000 000000 0
To view Enzybel’s complete investors history, request access »

Enzybel FAQs

  • When was Enzybel founded?

    Enzybel was founded in 2006.

  • Who is the CEO of Enzybel?

    Vinoth Kannan is the CEO of Enzybel.

  • Where is Enzybel headquartered?

    Enzybel is headquartered in Waterloo, Belgium.

  • What is the size of Enzybel?

    Enzybel has 5 total employees.

  • What industry is Enzybel in?

    Enzybel’s primary industry is Specialty Chemicals.

  • Is Enzybel a private or public company?

    Enzybel is a Private company.

  • What is Enzybel’s current revenue?

    The current revenue for Enzybel is 00000.

  • Who are Enzybel’s investors?

    Science Center and Florinvest have invested in Enzybel.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »